These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7648968)

  • 1. Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.
    Collen MJ; Wirshup JF
    Dig Dis Sci; 1995 Aug; 40(8):1687-90. PubMed ID: 7648968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.
    Collen MJ; Johnson DA
    Dig Dis Sci; 1992 Apr; 37(4):570-6. PubMed ID: 1551347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
    Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric acid hypersecretion in refractory gastroesophageal reflux disease.
    Collen MJ; Lewis JH; Benjamin SB
    Gastroenterology; 1990 Mar; 98(3):654-61. PubMed ID: 2298369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
    Collen MJ; Johnson DA; Sheridan MJ
    Dig Dis Sci; 1994 Feb; 39(2):410-7. PubMed ID: 8313826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation.
    Collen MJ; Sheridan MJ
    Dig Dis Sci; 1991 Oct; 36(10):1371-6. PubMed ID: 1914757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
    Lewis JH
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():15-24. PubMed ID: 1888834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding duodenal ulcer. Role of gastric acid hypersecretion.
    Collen MJ; Kalloo AN; Sheridan MJ
    Dig Dis Sci; 1993 Feb; 38(2):269-75. PubMed ID: 8093870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
    Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome.
    Saeed ZA; Norton JA; Frank WO; Young MD; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1989 Jun; 96(6):1393-402. PubMed ID: 2565842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).
    Collen MJ; Stanczak VJ; Ciarleglio CA
    Dig Dis Sci; 1989 Feb; 34(2):233-7. PubMed ID: 2914544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
    Metz DC; Soffer E; Forsmark CE; Cryer B; Chey W; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2003 Feb; 98(2):301-7. PubMed ID: 12591045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.
    Collen MJ; Howard JM; McArthur KE; Raufman JP; Cornelius MJ; Ciarleglio CA; Gardner JD; Jensen RT
    Ann Intern Med; 1984 Jan; 100(1):52-8. PubMed ID: 6318628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
    Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
    Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of gastric acid hypersecretion in the Zollinger-Ellison syndrome with a thioamide derivative (40749 RP). Comparison with ranitidine].
    Bonfils S; Vallot T; Garcia del Risco F; Mignon M
    Gastroenterol Clin Biol; 1986; 10(6-7):486-91. PubMed ID: 3758592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.
    Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT
    Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.